NDUFAF1 Gene Mitochondrial complex I deficiency Genetic Test
Components: NDUFAF1 Gene Mitochondrial complex I deficiency Genetic Test
Price: 4400.0 AED
Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test Type: Neurological Disorders
Doctor: Neurologist
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for NDUFAF1 Gene Mitochondrial complex I deficiency NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with NDUFAF1 Gene Mitochondrial complex I deficiency.
Test Details:
The NDUFAF1 gene is responsible for encoding a protein that is involved in the assembly and stability of mitochondrial complex I, which is a crucial component of the mitochondrial respiratory chain. Mitochondrial complex I deficiency refers to a condition where there is a malfunction or deficiency in the function of this complex.
NGS (Next-Generation Sequencing) genetic testing is a high-throughput method used to analyze multiple genes simultaneously. In the context of mitochondrial complex I deficiency, NGS genetic testing can be used to identify mutations or variations in the NDUFAF1 gene that may be responsible for the deficiency. By sequencing the DNA of an individual, NGS can identify specific genetic changes that may be affecting the function of the NDUFAF1 gene.
This information can help diagnose mitochondrial complex I deficiency and guide treatment decisions. NGS genetic testing is particularly useful in cases where there is a suspected genetic cause for the condition, as it allows for the simultaneous analysis of multiple genes. This can help identify other genetic variants that may be contributing to the deficiency and provide a more comprehensive understanding of the underlying genetic factors involved.
Overall, NGS genetic testing of the NDUFAF1 gene can help diagnose mitochondrial complex I deficiency and provide valuable information for the management and treatment of affected individuals.
Test Name | NDUFAF1 Gene Mitochondrial complex I deficiency Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Neurological Disorders |
Doctor | Neurologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for NDUFAF1 Gene Mitochondrial complex I deficiency NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with NDUFAF1 Gene Mitochondrial complex I deficiency |
Test Details | The NDUFAF1 gene is responsible for encoding a protein that is involved in the assembly and stability of mitochondrial complex I, which is a crucial component of the mitochondrial respiratory chain. Mitochondrial complex I deficiency refers to a condition where there is a malfunction or deficiency in the function of this complex. NGS (Next-Generation Sequencing) genetic testing is a high-throughput method used to analyze multiple genes simultaneously. In the context of mitochondrial complex I deficiency, NGS genetic testing can be used to identify mutations or variations in the NDUFAF1 gene that may be responsible for the deficiency. By sequencing the DNA of an individual, NGS can identify specific genetic changes that may be affecting the function of the NDUFAF1 gene. This information can help diagnose mitochondrial complex I deficiency and guide treatment decisions. NGS genetic testing is particularly useful in cases where there is a suspected genetic cause for the condition, as it allows for the simultaneous analysis of multiple genes. This can help identify other genetic variants that may be contributing to the deficiency and provide a more comprehensive understanding of the underlying genetic factors involved. Overall, NGS genetic testing of the NDUFAF1 gene can help diagnose mitochondrial complex I deficiency and provide valuable information for the management and treatment of affected individuals. |